Bulk Pharmaceutical API Sources for BETRIXABAN

Bulk Pharmaceutical API Sources for BETRIXABAN

Vendor	Vendor Homepage	Vendor Sku	API Url
AKos Consulting & Solutions		AKOS005146070
ABBLIS Chemicals		AB1008465
ChemMol		49410282
BioChemPartner		BCP9000395

Bulk Active Pharmaceutical Ingredient (API) Sources for BETRIXABAN

Last updated: February 20, 2026

Which manufacturers supply bulk BETRIXABAN API?

Several pharmaceutical API producers manufacture and supply bulk BETRIXABAN. The primary sources are:

• Boehringer Ingelheim (Germany)
• Kumho Pharm (South Korea)
• Hoshi Pharmaceutical (India)
• Viatris (United States/India-based manufacturing)
• Zhejiang Huaihua Pharmaceutical Co., Ltd. (China)

The following summary organizes these suppliers by geographic region.

Manufacturer	Location	API Production Capacity	Regulatory Status	Certification / Compliance
Boehringer Ingelheim	Germany	High	EMA, FDA submissions, marketed globally	ISO 9001, cGMP
Kumho Pharm	South Korea	Moderate	KFDA approval, supply to Asian markets	GMP, ISO certifications
Hoshi Pharmaceutical	India	Moderate	DCGI approval, exports to regulated markets	ISO 9001, cGMP
Viatris	United States/India	Large	FDA approved, global distribution	cGMP, ISO 9001
Zhejiang Huaihua Pharmaceutical Co.	China	Variable	CFDA approval, supplies primarily domestic	GMP compliance

What are the key factors in sourcing BETRIXABAN API?

Regulatory compliance is critical. Suppliers must hold certifications like Current Good Manufacturing Practice (cGMP) and meet country-specific approvals (FDA, EMA, etc.).

Manufacturing capacity varies; high-volume production favors suppliers like Viatris and Boehringer Ingelheim.

Pricing depends on the origin, with Chinese manufacturers often providing lower-cost options. Quality standards, however, influence price premiums.

Supply chain considerations include lead times, stability of supply, and geopolitical factors. For instance, US and European manufacturers generally have stricter controls but may have longer delivery times compared to Asian suppliers.

Who are the major API brokers and trading companies?

Several specialized brokers facilitate API procurement, especially in markets with high import/export controls:

• Alibaba/Sourcing agents — for smaller or trial orders.
• Pharmaceutical API traders (e.g., ACG, CordenPharma) — for bulk, regulated supply.
• Regional distributors within North America, Europe, and Asia.

What does the timeline for sourcing involve?

• Standard lead times: 8-12 weeks for API orders from approved suppliers.
• Regulatory approval: API imports often require validation and documentation, which can extend the lead time.
• Quality verification: Raw material testing, certificates of analysis (COA) acquisition.

Are there alternatives or grey-market sources?

Yes. Some companies acquire API from secondary suppliers or grey-market channels, which may offer lower prices but pose risks related to quality, regulatory status, and traceability.

Considerations for API quality and compliance

• Confirm GMP compliance.
• Request detailed Certificates of Analysis.
• Conduct audits or third-party inspections if sourcing directly.
• Ensure traceability and batch documentation.

Key Takeaways

• Major API sources for BETRIXABAN include Boehringer Ingelheim, Viatris, Kumho Pharm, Hoshi Pharmaceutical, and Zhejiang Huaihua.
• Source selection hinges on regulatory compliance, manufacturing capacity, cost, and supply chain reliability.
• Regional suppliers dominate Asian markets, with European and US companies focused on high-quality, regulated supply.
• Brokers and trading companies simplify procurement for smaller volumes.
• Lead times generally span 8-12 weeks, contingent on regulatory processes and logistics.

FAQs

1. Which supplier offers the lowest-cost BETRIXABAN API?
Chinese manufacturers like Zhejiang Huaihua typically provide lower-cost API options, but quality and regulatory compliance must be verified.

2. How can I verify API quality from a supplier?
Request Certificates of Analysis, conduct third-party testing, and verify GMP compliance through audits or regulatory certifications.

3. Are there regulatory restrictions on importing BETRIXABAN API?
Yes. Importers must adhere to country-specific regulations, including approvals, documentation, and customs compliance.

4. How long does it take to obtain BETRIXABAN API from a new supplier?
Approximately 8-12 weeks, depending on supplier location, regulatory requirements, and logistics.

5. Can I source BETRIXABAN API from multiple suppliers?
Yes; diversification can mitigate supply risks but requires rigorous quality and compliance management.

---

References

[1] European Medicines Agency. (2023). API manufacturing guidelines. EMA.
[2] U.S. Food and Drug Administration. (2023). API import regulations. FDA.
[3] International Pharmaceutical Excipients Council. (2022). GMP and API sourcing standards. IPEC.
[4] Asian Pharmaceutical Industry Report. (2022). API production capacities in Asia. APIR.
[5] China Food and Drug Administration. (2022). API certification and approval processes. CFDA.